Bottom line
HGHRX vs JDOC: the short answer
HGHRX (The Hartford Healthcare Fund) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
JDOC is cheaper at 0.65% vs 1.66% — a difference of $101 a year per $10,000 invested.
Updated Nov 19, 2026
HGHRX vs JDOC side by side
| HGHRX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Hartford | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.66% | 0.65% |
| Annual cost per $10k | $166 | $65 |
| 10-yr cost on $10k (prospectus) | $1,965 | $810 |
| Max front load | 0% | None |
| 12b-1 fee | 0.5% | — |
| 1-yr return | — | +14.9% |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | — | +11.3% |
| Worst quarter | — | −11.9% |
| Net assets (fund) | $772.2M | $9.1M |
| Number of holdings | 80 | 61 |
| Portfolio turnover | 49% | 92% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of HGHRX's top 25 holdings also appear in JDOC's top 25.
| Holding | HGHRX | JDOC |
|---|---|---|
| Eli Lilly & Co | 12.03% | 7.76% |
| Johnson & Johnson | 6.75% | 4.82% |
| Merck & Co Inc | 6.00% | 4.82% |
| UnitedHealth Group Inc | 4.74% | 5.85% |
| AbbVie Inc | 4.21% | 7.85% |
| Intuitive Surgical Inc | 2.88% | 1.93% |
| CVS Health Corp | 2.84% | 2.83% |
| Danaher Corp | 2.57% | 2.16% |
| Edwards Lifesciences Corp | 2.48% | 1.73% |
| Cencora Inc | 2.46% | 2.07% |
| Regeneron Pharmaceuticals Inc | 2.02% | 1.60% |
| Abbott Laboratories | 1.82% | 3.11% |
| Thermo Fisher Scientific Inc | 1.58% | 3.73% |
| Biogen Inc | 1.36% | 1.56% |
| Stryker Corp | 1.24% | 2.23% |
Source: SEC Form N-PORT
HGHRX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between HGHRX and JDOC?
HGHRX (The Hartford Healthcare Fund) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds. JDOC is cheaper at 0.65% vs 1.66% — a difference of $101 a year per $10,000 invested.
Which is cheaper, HGHRX or JDOC?
JDOC has the lower expense ratio (0.65%).
Should I own both HGHRX and JDOC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.